NCT04636073View on ClinicalTrials.gov

The Leaflex™ Early Feasibility Study

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Aortic Valve Stenosis
Interventions
DEVICE

Leaflex™ Performer

A transfemoral catheter designed to treat calcific aortic stenosis by scoring the calcification in the aortic valve leaflets.

Sponsors

Lead Sponsor

Pi-cardia
All Listed Sponsors
lead

Pi-cardia

INDUSTRY

NCT04636073 - The Leaflex™ Early Feasibility Study | Biotech Hunter | Biotech Hunter